Cancer treatment is constantly evolving as new therapies emerge. This is thanks, in large part, to the volunteers and researchers who participate in clinical trials. The findings of these trials can help lead to new, effective treatment regimens. Clinical trials can be a great way for cancer patients to receive the treatment they need while advancing science and benefitting other cancer patients. These studies have their risks and benefits, but if you meet the eligibility criteria, they are worth considering and consulting your doctor about. The RCCA medical library provides resources for you to become more acquainted with the ins and outs of clinical trials and different types of cancer care.
Deciding if clinical trials are right for you should be up to you, your doctor, and your loved ones. Everyone has different circumstances, so it is important for you and your doctor to weigh the risks and benefits. For example, a study may have unknown results. However, the benefit of receiving potentially ground-breaking cancer treatment while monitoring your progress at all times may outweigh this risk. It is also worth noting that trial participants are not bound to the study in which they participate. They can leave at any time.
Different trials have different criteria for you to be eligible to volunteer for the study. This criteria may be based on age, gender, stage and type of cancer, previous treatment, and other medical conditions. Explore the various clinical trials available and determine if you are eligible to participate and potentially receive this cancer treatment.
If you decide to take part in a clinical trial, it is necessary for you to be informed about the study and to provide consent that you are willing to participate. You should receive information detailing the purpose of the trial, eligibility criteria, potential risks and benefits, other treatments available, and trial design for you to review before deciding on the trial.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.